Pacira BioSciences Inc. (PCRX)
NASDAQ · Healthcare
Pacira BioSciences Inc. Operating Income 2009–2025
Pacira BioSciences Inc. annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Pacira BioSciences Inc. operating income for the quarter ending March 31, 2026 was 6.9 M, a 246.83% increase year-over-year.
- Pacira BioSciences Inc. operating income for the twelve months ending March 31, 2026 was 23.8 M, a 129.56% decrease year-over-year.
- Pacira BioSciences Inc. annual operating income for 2025 was 19.2 M, a 126.16% decrease from 2024.
- Pacira BioSciences Inc. annual operating income for 2024 was -73.4 M, a 183.69% decrease from 2023.
- Pacira BioSciences Inc. annual operating income for 2023 was 87.7 M, a 46.07% increase from 2022.
- Pacira BioSciences Inc. annual operating income for 2022 was 60.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Pacira BioSciences Inc. Operating Income — FAQ
Pacira BioSciences Inc. (PCRX) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Pacira BioSciences Inc.'s operating income?
Pacira BioSciences Inc. (PCRX) reported operating income of $19M for fiscal 2025.
Where can I see PCRX's operating income history?
The chart and table above show Pacira BioSciences Inc.'s operating income by year and by quarter, including the growth rate.